| Reference : Decreased prevalence of atopic diseases in children with diabetes |
| Scientific journals : Article | |||
| Human health sciences : Multidisciplinary, general & others | |||
| http://hdl.handle.net/10993/27218 | |||
| Decreased prevalence of atopic diseases in children with diabetes | |
| English | |
De Beaufort, Carine  [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >] | |
| 2000 | |
| Journal of Pediatrics | |
| Mosby | |
| 137 | |
| 470-474 | |
| Yes (verified by ORBilu) | |
| 0022-3476 | |
| 1097-6833 | |
| St Louis | |
| MO | |
| [en] atopic diseases ; children ; diabetes ; risk ; protection ; type 1 | |
| [en] OBJECTIVE:
To test the hypothesis that atopic diseases in early life are associated with a reduced risk (protection) for the development of type 1 diabetes in childhood. STUDY DESIGN: European centers (n = 8) with access to population-based type 1 diabetes registries (>90% degree of ascertainment) participated in a case control study focusing on early exposures and risk factors for type 1 diabetes. Altogether, data from 1028 members of a case group and 2744 members of a control group corresponding to 85.4% eligible members of the case group and 76.1% of the control group were analyzed. Information in this study was collected regarding atopic diseases (atopic eczema, allergic rhinoconjunctivitis, and asthma). RESULTS: Atopic disease and asthma particularly are associated with significant reductions in risk of childhood type 1 diabetes. The risk reduction associated with asthma was observed reasonably consistently among the 8 study centers, which represent a wide range of diabetes incidence. Risk reductions associated with all 3 expressions of atopy were particularly marked in children whose type 1 diabetes was diagnosed in the 10- to 14-year age group. CONCLUSION: These findings indicate that atopic conditions may be protective against the development of type 1 diabetes and are consistent with the immunologic concept of T(H)1 (type 1 diabetes) and T(H)2 (atopy) diseases being mutually exclusive. | |
| Eurodiab Substudy 2 Study Group | |
| http://hdl.handle.net/10993/27218 |
There is no file associated with this reference.
All documents in ORBilu are protected by a user license.
